Technology News

New Debut this December, The Standard, Singapore

The Brand\'s Fifth Asia Pacific Property will be an Urban Sanctuary in the Heart of the City BANGKOK,Dec. 16,2024--The Standard,Singaporehas officially opened its doors on December 15,2024. The proper

Innovent and Lilly Expand Collaboration Through Agreement on Commercialization Rights for Jaypirca® (pirtobrutinib) in Mainland China

SAN FRANCISCO andSUZHOU,China,Dec. 16,2024-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high-qua

MoonFox Analysis | Online Travel Platforms Empower Double 11 Shopping Festival, "Competing" to Drive Growth and New Trends

About us: Aurora Mobile (NASDAQ: JG) established in 2011,is a leading customer engagement and marketing technology service provider in China. Its business includes notification services,marketing grow

aiMotive and Safran collaborate to make ADAS & AD development safer

MOUNTAIN VIEW,Calif.,Dec. 17,2024-- aiMotive,a leading provider of cutting-edge simulation and AI technologies,has joined forces with Safran Electronics & Defense to advance the testing and valid

Multiplier Taps Industry Leaders from Nium and Paycor to Accelerate Growth

NEW YORK,Dec. 17,2024-- Multiplier,a leading global employment platform,announced today the appointments of Pratik Gandhi as Managing Director and Chief Operating Officer (MD & COO) and Matt Carr

Hyundai Mobis Tackles Electric Vehicle Battery Overheating with its New Material Technology

SEOUL,South Korea,Dec. 18,2024-- HyundaiMobis (KRX 012330) announced on 18th that it has developed a new battery cell cooling material to prevent battery overheating during ultra-fast charging of ele

Everest Medicines Announces the First Prescription of VELSIPITY® in the Greater Bay Area, Officially Benefiting Mainland China Patients

SHANGHAI,Dec. 18,2024-- Everest Medicines (HKEX 1952.HK,"Everest",or the "Company"),a biopharmaceutical company focused on the discovery,clinical development,manufacturing and comm

Neurizon Files IND Application to Support HEALEY ALS Platform Trial

Highlights: IND application submission to the U.S. Food and Drug Administration (FDA) is a pivotal step in initiating a Phase 2/3 clinical study for NUZ-001

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

ADELA,an international phase III study being conducted across multiple countries,combines elacestrant with everolimus to treat advanced ER+/HER2- breast cancer with ESR1 mutations,aiming to delay dis

2024 SABCS|Results Unveiled for the Phase III Study of Disitamab Vedotin in Treating HER2-Positive Advanced Breast Cancer with Liver Metastasis

YANTAI,China,Dec. 13,2024-- On the morning of December 12,2024 (UTC-6),at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium (SABCS),Reme

Home Previous 49 50 51 52 53 54 55 Next Tail

10 Items Per Page (Page 52 / 153) Total 1522 Items

©copyright 2009-2020 iots Daily      Contact Us   SiteMap